Literature DB >> 29319819

Development and External Validation of Risk Scores for Cardiovascular Hospitalization and Rehospitalization in Patients With Diabetes.

Dahai Yu1,2, Yamei Cai1, Jonathan Graffy3, Daniel Holman4, Zhanzheng Zhao1, David Simmons5.   

Abstract

Context: Cardiovascular disease (CVD) is a common and costly reason for hospitalization and rehospitalization among patients with type 2 diabetes. Objective: This study aimed to develop and externally validate two risk-prediction models for cardiovascular hospitalization and cardiovascular rehospitalization. Design: Two independent prospective cohorts. Setting: The derivation cohort includes 4704 patients with type 2 diabetes from 18 general practices in Cambridgeshire. The validation cohort comprises 1121 patients with type 2 diabetes from post-trial follow-up data. Main Outcome Measure: Cardiovascular hospitalization over 2 years and cardiovascular rehospitalization after 90 days of the prior CVD hospitalization.
Results: The absolute rate of cardiovascular hospitalization and rehospitalization was 12.5% and 6.7% in the derivation cohort and 16.3% and 7.0% in the validation cohort. Discrimination of the models was similar in both cohorts, with C statistics above 0.70 and excellent calibration of observed and predicted risks.
Conclusion: Two prediction models that quantify risks of cardiovascular hospitalization and rehospitalization have been developed and externally validated. They are based on a small number of clinical measurements that are available for patients with type 2 diabetes in many developed countries in primary care settings and could serve as the tools to screen the population at high risk of cardiovascular hospitalization and rehospitalization.

Entities:  

Mesh:

Year:  2018        PMID: 29319819     DOI: 10.1210/jc.2017-02293

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Application of standardised effect sizes to hospital discharge outcomes for people with diabetes.

Authors:  Tim Robbins; Sarah N Lim Choi Keung; Sailesh Sankar; Harpal Randeva; Theodoros N Arvanitis
Journal:  BMC Med Inform Decis Mak       Date:  2020-07-07       Impact factor: 2.796

2.  4-Pyridoxic Acid/Pyridoxine Ratio in Patients with Type 2 Diabetes is Related to Global Cardiovascular Risk Scores.

Authors:  Rima Obeid; Juergen Geisel; Wilfred A Nix
Journal:  Diagnostics (Basel)       Date:  2019-03-06

3.  Optimal cut-off threshold in pulse pressure predicting cardiovascular death among newly diagnosed end-stage renal disease patients: A prospective cohort study.

Authors:  Zheng Wang; Dahai Yu; Yamei Cai; Bin Zhao; Xiaoxue Zhang; Zhanzheng Zhao
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study.

Authors:  Jin Shang; Dahai Yu; Yamei Cai; Zheng Wang; Bin Zhao; Zhanzheng Zhao; David Simmons
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

5.  Cardiovascular risks and bleeding with non-vitamin K antagonist oral anticoagulant versus warfarin in patients with type 2 diabetes: a tapered matching cohort study.

Authors:  Dahai Yu; Zhanzheng Zhao; David Simmons
Journal:  Cardiovasc Diabetol       Date:  2020-10-10       Impact factor: 9.951

6.  Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims.

Authors:  Alessandro Battaggia; Angelo Avogaro; Gian Paolo Fadini; Barbara Di Camillo; Alessandro Guazzo; Enrico Longato; Mario Luca Morieri; Giovanni Sparacino; Bruno Franco-Novelletto; Maurizio Cancian; Massimo Fusello; Lara Tramontan
Journal:  Sci Rep       Date:  2022-05-11       Impact factor: 4.996

7.  Total/high density lipoprotein cholesterol and cardiovascular disease (re)hospitalization nadir in type 2 diabetes.

Authors:  Dahai Yu; Yamei Cai; Rui Qin; Jonathan Graffy; Daniel Holman; Zhanzheng Zhao; David Simmons
Journal:  J Lipid Res       Date:  2018-06-29       Impact factor: 5.922

8.  Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.

Authors:  Dahai Yu; Jin Shang; Yamei Cai; Zheng Wang; Xiaoxue Zhang; Bin Zhao; Zhanzheng Zhao; David Simmons
Journal:  BMJ Open Diabetes Res Care       Date:  2019-11-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.